Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

[1]  J. Onwude.  Hormone therapy and ovarian cancer , 2015, The Lancet.

[2]  A. Gompel,et al.  Updated 2013 international menopause society recommendations on menopausal hormone therapy and preventive strategies for midlife health , 2014 .

[3]  R. Langer,et al.  Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health , 2013, Climacteric : the journal of the International Menopause Society.

[4]  Andy H. Lee,et al.  Tea consumption reduces ovarian cancer risk. , 2013, Cancer epidemiology.

[5]  Heather Eliassen,et al.  Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies , 2012, The Lancet. Oncology.

[6]  M. Sherman,et al.  Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study , 2012, British Journal of Cancer.

[7]  S. Bowlin,et al.  A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women’s Health Initiative , 2012, Menopause.

[8]  Andy H. Lee,et al.  Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies , 2012, The Lancet. Oncology.

[9]  Andy H. Lee,et al.  Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies , 2012, PLoS medicine.

[10]  C. Bunker,et al.  Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drugs, or Acetaminophen and Risk of Ovarian Cancer , 2012, Epidemiology.

[11]  I. Shih,et al.  Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. , 2011, Human pathology.

[12]  J. Gohagan,et al.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. , 2011, JAMA.

[13]  I. Gram,et al.  Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition , 2011, Cancer Causes & Control.

[14]  M. Thun,et al.  Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen , 2010, International journal of cancer.

[15]  L. Bernstein,et al.  Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort , 2010, Cancer Causes & Control.

[16]  S. Larsson,et al.  Long-Term Dietary Acrylamide Intake and Risk of Epithelial Ovarian Cancer in a Prospective Cohort of Swedish Women , 2009, Cancer Epidemiology Biomarkers & Prevention.

[17]  Helen Farrugia,et al.  Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia , 2009, The Medical journal of Australia.

[18]  Lewis H Kuller,et al.  Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. , 2008, American journal of epidemiology.

[19]  I. Gram,et al.  Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer , 2008, International journal of cancer.

[20]  N. Weiss,et al.  Menopausal Hormone Therapy and Risk of Epithelial Ovarian Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[21]  Jane Green,et al.  Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005 , 2007, European Journal of Clinical Pharmacology.

[22]  V. Beral.  Ovarian cancer and hormone replacement therapy in the Million Women Study , 2007, The Lancet.

[23]  S. Chanock,et al.  Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study , 2007, BMC Cancer.

[24]  G. Colditz,et al.  A prospective study of postmenopausal hormone use and ovarian cancer risk , 2006, British Journal of Cancer.

[25]  W. Willett,et al.  Relation of Anthropometric Measurements to Ovarian Cancer Risk in a Population-based Case–control Study (United States) , 2006, Cancer Causes & Control.

[26]  Stephen Evans,et al.  Medicines and Healthcare Products Regulatory Agency (MHRA) (Formerly MCA) , 2005 .

[27]  A. Berchuck,et al.  Menopausal hormones and risk of ovarian cancer. , 2005, American journal of obstetrics and gynecology.

[28]  E. Flagg,et al.  A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. , 2004, American journal of epidemiology.

[29]  S. Tonstad,et al.  Hormone therapy and mortality during a 14‐year follow‐up of 14 324 Norwegian women , 2004, Journal of internal medicine.

[30]  M. Pike,et al.  Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. , 2004, Fertility and sterility.

[31]  M. Plummer.  Improved estimates of floating absolute risk , 2004, Statistics in medicine.

[32]  A. Folsom,et al.  Estrogen Replacement Therapy and Ovarian Cancer , 2004, Epidemiology.

[33]  J. Freudenheim,et al.  Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. , 2003, The Journal of nutrition.

[34]  H. Olsson,et al.  Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden , 2003, Cancer.

[35]  J. Weissfeld,et al.  Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma. , 2002, Gynecologic oncology.

[36]  P. Hartge,et al.  Menopausal hormone replacement therapy and risk of ovarian cancer. , 2002, JAMA.

[37]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[38]  L. Kolonel,et al.  Association of dairy products, lactose, and calcium with the risk of ovarian cancer. , 2002, American journal of epidemiology.

[39]  E. Weiderpass,et al.  Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. , 2002, Journal of the National Cancer Institute.

[40]  J. Chang-Claude,et al.  Low‐dose oral contraceptives: Protective effect on ovarian cancer risk , 2001, International journal of cancer.

[41]  M. Thun,et al.  Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. , 2001, JAMA.

[42]  C. la Vecchia,et al.  Reproductive and hormonal factors and ovarian cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[43]  N. Hacker,et al.  Hormone replacement therapy and risk of epithelial ovarian cancer , 1999, British Journal of Cancer.

[44]  Weber Am.  Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study. , 1997, Obstetrics and gynecology.

[45]  S. Kjaer,et al.  Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. , 1997, Fertility and sterility.

[46]  H. Risch.  Estrogen replacement therapy and risk of epithelial ovarian cancer. , 1996, Gynecologic oncology.

[47]  D. Wysowski,et al.  Use of Menopausal Estrogens and Medroxyprogesterone in the United States, 1982–1992 , 1995, Obstetrics and gynecology.

[48]  D. Trichopoulos,et al.  Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer , 1993, International journal of cancer.

[49]  C. la Vecchia,et al.  Oral contraceptive use and the risk of ovarian cancer: an Italian case-control study. , 1991, European journal of cancer.

[50]  C. Muir,et al.  International Classification of Diseases for Oncology , 1990 .

[51]  S. Shapiro,et al.  Noncontraceptive estrogen use and epithelial ovarian cancer. , 1989, American journal of epidemiology.

[52]  V. Beral,et al.  Risk factors for ovarian cancer: a case-control study. , 1989, British Journal of Cancer.

[53]  A. Whittemore,et al.  Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. , 1988, American journal of epidemiology.

[54]  A. Whittemore,et al.  Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. , 1988, American journal of epidemiology.

[55]  P. Hartge,et al.  Menopause and ovarian cancer. , 1988, American journal of epidemiology.

[56]  D. Kennedy,et al.  Noncontraceptive estrogens and progestins: use patterns over time. , 1985, Obstetrics and gynecology.

[57]  P. Nasca,et al.  An epidemiologic case-control study of ovarian cancer and reproductive factors. , 1984, American journal of epidemiology.

[58]  T. Byers,et al.  A case-control study of dietary and nondietary factors in ovarian cancer. , 1983, Journal of the National Cancer Institute.

[59]  D. Cramer,et al.  Ovarian cancer and talc. A case‐control study , 1982, Cancer.

[60]  J. Kelsey,et al.  An epidemiologic study of epithelial carcinoma of the ovary. , 1981, American journal of epidemiology.

[61]  W. Lednar,et al.  The woman at risk for developing ovarian cancer. , 1979, Gynecologic oncology.

[62]  M. Newhouse,et al.  A case control study of carcinoma of the ovary. , 1977, British journal of preventive & social medicine.

[63]  Collaborative group on hormonal factors in breast cancer , 2011 .

[64]  L. Schouten,et al.  Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls , 2009 .

[65]  J. Stockman.  Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioners' oral contraception study , 2009 .

[66]  E. Friedman,et al.  Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  R. Cress,et al.  Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk. , 2005, Cancer detection and prevention.

[68]  Andy H. Lee,et al.  Reproductive and dietary risk factors for epithelial ovarian cancer in China. , 2004, Gynecologic oncology.

[69]  D. Cramer,et al.  A case-control study of galactose consumption and metabolism in relation to ovarian cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[70]  S. E. Dietert,et al.  Noncontraceptive estrogen use and the occurrence of ovarian cancer. , 1982, Journal of the National Cancer Institute.

[71]  Montclair State University Digital Montclair State University Digital Commons Commons Dietary fiber intake and ovarian cancer risk: a prospective cohort Dietary fiber intake and ovarian cancer risk: a prospective cohort study study , 2022 .

[72]  R. Goldbohm,et al.  American Journal of Epidemiology Original Contribution Reproductive and Hormonal Factors in Association with Ovarian Cancer in the Netherlands Cohort Study the Prospective Netherlands Cohort Study on Diet and Cancer Started in September 1986 with the Enrollment Of , 2022 .